Insider · CIK 0001310683

Culley Brian M

Reports to the SEC for 3 companies · CARLSBAD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001310683

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-12	LCTXLineage Cell Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+15K sh	$1.63	+$24.4K	255,516
2026-03-05	LCTXLineage Cell Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+3.25M sh	—	—	3,250,000
2026-02-11	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−31.3K sh	—	—	0
2026-02-11	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−12.9K sh	$1.80	−$23.2K	240,516
2026-02-11	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+31.3K sh	—	—	253,385
2025-12-19	LCTXLineage Cell Therapeutics, Inc.A Award	Director, President and CEO	AAward	+8,925 sh	—	—	222,469
2025-12-19	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−334 sh	$1.68	−$561.12	222,135
2025-03-10	LCTXLineage Cell Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+2.3M sh	—	—	2,300,000
2025-02-11	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+31.2K sh	—	—	226,091
2025-02-11	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−12.5K sh	$0.65	−$8,155.55	213,544
2025-02-11	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−31.2K sh	—	—	31,250
2024-11-21	LCTXLineage Cell Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+40K sh	$0.60	+$24K	194,842
2024-05-24	LCTXLineage Cell Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+10K sh	$1.05	+$10.5K	154,842
2024-03-07	LCTXLineage Cell Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+1.9M sh	—	—	1,900,000
2024-02-11	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−31.2K sh	—	—	62,499
2024-02-11	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+31.2K sh	—	—	157,648
2024-02-11	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−12.8K sh	$1.08	−$13.8K	144,842
2023-03-09	LCTXLineage Cell Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+1.9M sh	—	—	1,900,000
2023-02-11	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−31.2K sh	—	—	93,748
2023-02-11	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+31.2K sh	—	—	139,143
2023-02-11	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−12.7K sh	$1.35	−$17.2K	126,399
2022-06-30	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−15.5K sh	—	—	0
2022-06-30	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+15.5K sh	—	—	113,237
2022-06-30	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−5,343 sh	$1.58	−$8,441.94	107,894
2022-03-31	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−5,343 sh	$1.54	−$8,228.22	91,387
2022-03-31	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+15.5K sh	—	—	96,730
2022-03-31	LCTXLineage Cell Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+6,400 sh	$1.53	+$9,792	97,787
2022-03-31	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−15.5K sh	—	—	15,450
2022-03-25	LCTXLineage Cell Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+5,250 sh	$1.38	+$7,245	81,280
2022-03-10	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsA Award	Director, President and CEO	AAward	+300K sh	—	—	300,000
2022-03-10	LCTXLineage Cell Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+1.25M sh	—	—	1,250,000
2022-02-11	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsA Award	Director, President and CEO	AAward	+125K sh	—	—	124,997
2021-12-31	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−15.5K sh	—	—	30,900
2021-12-31	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−5,343 sh	$2.45	−$13.1K	76,030
2021-12-31	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+15.5K sh	—	—	81,373
2021-09-30	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−15.5K sh	—	—	46,350
2021-09-30	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−5,343 sh	$2.52	−$13.5K	65,923
2021-09-30	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+15.5K sh	—	—	71,266
2021-06-30	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−15.5K sh	—	—	61,800
2021-06-30	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+15.5K sh	$2.85	+$44K	61,159
2021-06-30	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−5,343 sh	$2.85	−$15.2K	55,816
2021-06-28	LCTXLineage Cell Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−300K sh	—	—	933,300
2021-06-28	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+300K sh	$0.69	+$208K	495,709
2021-06-28	LCTXLineage Cell Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−450K sh	$2.87	−$1.29M	45,709
2021-03-31	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−5,343 sh	$2.35	−$12.6K	195,709
2021-03-31	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+15.5K sh	$2.35	+$36.3K	201,052
2021-03-31	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−15.5K sh	—	—	77,250
2021-03-15	LCTXLineage Cell Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+1.17M sh	—	—	1,165,100
2020-12-31	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−5,343 sh	$1.76	−$9,403.68	185,602
2020-12-31	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−15.5K sh	—	—	92,700

Recent filings

Accepted (ET)
Mar 124
Culley Brian M0001193125-26-104106
SEC(opens sec.gov)
Mar 64
Culley Brian M0001193125-26-097185
SEC(opens sec.gov)
Feb 134
Culley Brian M0001193125-26-052021
SEC(opens sec.gov)
Dec 194
Culley Brian M0001193125-25-327280
SEC(opens sec.gov)
Mar 124
Culley Brian M0000950170-25-038117
SEC(opens sec.gov)
Feb 124
Culley Brian M0000950170-25-018887
SEC(opens sec.gov)
Nov 224
Culley Brian M0000950170-24-129972
SEC(opens sec.gov)
May 284
Culley Brian M0000950170-24-064896
SEC(opens sec.gov)
Mar 84
Culley Brian M0001493152-24-009382
SEC(opens sec.gov)
Feb 124
Culley Brian M0001493152-24-005942
SEC(opens sec.gov)
Mar 104
Culley Brian M0001493152-23-007306
SEC(opens sec.gov)
Feb 144
Culley Brian M0001493152-23-004898
SEC(opens sec.gov)

Companies

Address

C/O LINEAGE CELL THERAPEUTICS 2173 SALK AVENUE, SUITE 200

CARLSBAD, CA, 92008